Page last updated: 2024-10-28

gw8510 and Lung Neoplasms

gw8510 has been researched along with Lung Neoplasms in 2 studies

GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source

Lung Neoplasms: Tumors or cancer of the LUNG.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P1
Wu, JN1
Shu, Y1
Jiang, HG1
Zhao, XH1
Qian, H1
Chen, K1
Lan, T1
Chen, CG1
Li, J1
Dong, F1
Guo, W1
Zhang, L1
Wu, S1
Teraishi, F1
Davis, JJ1
Fang, B1

Other Studies

2 other studies available for gw8510 and Lung Neoplasms

ArticleYear
Gemcitabine resistance mediated by ribonucleotide reductase M2 in lung squamous cell carcinoma is reversed by GW8510 through autophagy induction.
    Clinical science (London, England : 1979), 2018, 07-16, Volume: 132, Issue:13

    Topics: Animals; Antimetabolites, Antineoplastic; Autophagy; Carcinoma, Squamous Cell; Deoxycytidine; Down-R

2018
Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells.
    Cancer biology & therapy, 2006, Volume: 5, Issue:2

    Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cyclin-Dependent Kinases; Down-Regulation; Humans; Indole

2006